Nominations open for CSL Florey Medal
Nominations are now open for the $50,000 biennial CSL Florey Medal, established by the Australian Institute of Policy and Science (AIPS) in 1998 to celebrate the 100th anniversary of the birth of Sir Howard Florey.
Sir Howard Florey took penicillin from an idea to a drug that has saved literally hundreds of millions of lives.
The CSL Florey Medal honours Australian researchers who have made significant achievements in biomedical science and/or in advancing human health.
The following conditions apply:
- nominees should have completed a significant portion of their nominated research achievements in Australia
- nominations will be accepted for an individual, and for up to three named persons for joint nominations - full research teams are not eligible
- self-nominations are not eligible
- nominees must be permanent residents or citizens of Australia
- although the selection criteria focus on research achievements, nominations from those working in industry or government sectors and demonstrating an equally high level of achievement are encouraged.
The winner will receive a silver medal and a $50,000 cheque at the Association of Australian Medical Research Institutes’ annual dinner in Parliament House, Canberra, on Monday 28 October 2013.
Since 1998, the prize has been awarded seven times: Graeme Clark (2011), John Hopwood (2009), Ian Frazer (2006), Peter Colman (2004), Colin Masters (2002), Jacques Miller (2000), Robin Warren and Barry Marshall (1998).
The nomination process is straightforward, with a short online nomination form. Selection criteria, eligibility guidelines and conditions are also available.
Research project to produce fish-free omega-3
SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply...
Biodegradable smart patch can detect and treat blood clots
Researchers have developed a biodegradable smart patch that detects pressure changes and releases...
Biotech manufacturing facility opens in Brisbane
ENTRI, a purpose-built multimodal facility which will enable biotech companies to manufacture...
